abstract |
The invention provides a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and an immunomodulatory drug (eg for example, pomalidomide or lenalidomide). These combinations may also include an anti-inflammatory compound (eg, dexamethasone). |